Measurements of other new potential biomarkers for staging liver fibrosis such as fibulin-5, MMP-2 or TIMP-1 [31,32] further have the potential to improve the accuracy of non-invasive estimates of liver fibrosis. The gene discussed is MMP2; the disease is Hepatic fibrosis.